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This review focuses on the analysis and evaluation of the diverse senescence markers
suggested to prime red blood cells (RBC) for clearance in humans. These tags develop
in the course of biochemical and structural alterations accompanying RBC aging, as the
decrease of activities of multiple enzymes, the gradual accumulation of oxidative damage,
the loss of membrane in form of microvesicles, the redistribution of ions and alterations
in cell volume, density, and deformability. The actual tags represent the penultimate
galactosyl residues, revealed by desialylation of glycophorins, or the aggregates of the
anion exchanger (band 3 protein) to which anti-galactose antibodies bind in the first and
anti-band 3 naturally occurring antibodies (NAbs) in the second case. While anti-band 3
NAbs bind to the carbohydrate-free portion of band 3 aggregates in healthy humans,
induced anti-lactoferrin antibodies bind to the carbohydrate-containing portion of band
3 and along with anti-band 3 NAbs may accelerated clearance of senescent RBC in
patients with anti-neutrophil cytoplasmic antibodies (ANCA). Exoplasmically accessible
phosphatidylserine (PS) and the alterations in the interplay between CD47 on RBC and its
receptor on macrophages, signal regulatory protein alpha (SIRPalpha protein), were also
reported to induce erythrocyte clearance. We discuss the relevance of each mechanism
and analyze the strength of the data.
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RED BLOOD CELL AGEING PARAMETERS AND THE CRITERIA
OF EVALUATION
Over the years many investigators of red blood cells (RBC)
and their biochemical properties have centrifuged whole blood
and used the RBC pellet without actively removing leuco-
cytes/platelets, despite their simple and selective depletion has
been introduced and recommended almost 40 years ago by
Beutler et al. (1976). Many investigators did not add pro-
tease inhibitors to the buffers in which RBC and their mem-
branes/extracts were further processed. The omission of these
precautions has been and still is the major reason for deviat-
ing data. Omission of leucocyte removal has dramatic effects on
cell-age sensitive RBC properties, like e.g., hemolysis, echinocy-
tosis, vesicle release, phosphatidylserine (PS) exposure, and band
3 protein clusterization as carefully studied by Antonelou et al.
(2012). Thus, leucocyte-depletion renders transfusion of red
blood cell units stored for 3–7 days safe (Hod et al., 2011)
and ameliorates the effects of long stored blood (Phelan et al.,
2010). Hence, the value of a set of data is highly dependent
on having taken the first and where possible also the sec-
ond precaution and we have selected the data for the present
review accordingly. Other contradictions originate from a mis-
nomer, for example when authors claim to illustrate a RBC
property as a function of cell age, but compare properties
of energy-starved RBC with those of freshly isolated ones
(Girasole et al., 2012; Kim et al., 2012).
RBC undergo multiple changes while they age in vivo. Some
of these remain hidden within RBC, others affect the properties
of the cell directly, like the loss of cations and the loss of mem-
brane with some hemoglobin by vesiculation that result in an
increased cellular density. An increased density implies a higher
cell age as has been established by the decreased activities of a
number of intracellular enzymes, measured in the lysate (hexok-
inase, aldolase, pyruvate kinase, glutamate-oxalacetate transam-
inase) (Table 1). The decrease in activity of multiple enzymes
is, however, not linear with cell age, but almost exponential
from reticulocytes to mature cells [for a comprehensive review of
these aspects, see reference Clark (1988)]. This disadvantage has
forced many investigators to use as cell age parameters proper-
ties that change almost linearly with cell age, as exoplasmically
located acetylcholinesterase (Cohen et al., 1976), the RBC cre-
atine content (Fehr and Knob, 1979; Lutz and Fehr, 1979) and
the ratio of two Coomassie-blue stainable bands (the 4.1a/4.1b
ratio) (Mueller et al., 1987). This ratio illustrates the extent of
deamidation of band 4.1b and luckily results in a change of the
electrophoretic mobility of the protein in SDS polyacrylamide
gels (Inaba and Maede, 1988). The separation of RBC accord-
ing to their density has been achieved first by centrifuging RBC
in an angle rotor where cells circulate to some extent in this
highly viscous cell pellet (Murphy, 1973). With the availability of
Stractan and Percoll it is the material that establishes a gradient
or is arranged in a preformed gradient and allows RBC to better
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Table 1 | Changes in RBC properties associated with aging.
RBC property or Change of Change of activity with White cell Species Data obtained by References
enzyme studied activity cell age phase a/phase b removal Studied
METABOLIC ENZYMES
Lactate dehydrogenase/mg
protein
– Constant Yes Rabbit In vivo
biotinylation
Jindal et al., 1996
Phosphoglycerate kinase/mg
protein
– Constant Yes Rabbit In vivo
biotinylation
Jindal et al., 1996
Pyruvate kinase /mg protein – Constant Yes Rabbit In vivo
biotinylation
Jindal et al., 1996
Acid phosphatase/mg protein – Constant Yes Rabbit In vivo
biotinylation
Jindal et al., 1996
Pyruvate kinase/mg Hb D Exponential Yes Human Density Haram et al., 1991
Phosphofructokinase
(PFK)/Cell number
D Linear Yes Human Density +
Elutriation
Jansen et al., 1986
Glucose-6-phosphate
dehydrogenase (G6PD)/cell
number
D Linear Yes Human Density +
Elutriation
Jansen et al., 1986
Hexokinase/cell number or
mg/Hb
D Exponential/linear Yes Human Density +
Elutriation
Haram et al., 1991; Piomelli
and Seaman, 1993
KINASES
Membrane associated casein
kinase/mg protein
D Linear Yes Rabbit In vivo
biotinylaiton
Jindal et al., 1996
Membrane casein kinase
I/mg protein
D Linear Yes Human Density Jindal et al., 1996
Casein kinase I/mg
membrane protein
D Linear Yes Rabbit In vivo
biotinylaiton
Jindal et al., 1996
Membrane protein kinase C
(PKC)/mg protein
I Increase/linear Human Density Ramachandran and Abraham,
1989
Cytosolic protein kinase C
(PKC)/mg protein
D Exponential Yes Rabbit In vivo
biotinylation
Jindal et al., 1996
Cytosolic protein kinase C
(PKC)/mg protein
D Exponential Yes Human Density Jindal et al., 1996
Pyruvate kinase/cell number
(PK) or mgHb
D Exponential Yes Human Density +
Elutriation
Jansen et al., 1986; Piomelli
and Seaman, 1993
Cytosolic CKII/mg protein D Exponential Yes Human In vivo
biotinylation
Jindal et al., 1996
Cytosolic PKA/mg protein D Exponential/constant Yes Human/Rabbit Density Jindal et al., 1996
AMINO ACID MODIFICATIONS
Glutamate/oxalacetate
transaminase/mg Hb
D Exponential Yes Human Density Haram et al., 1991; Piomelli
and Seaman, 1993
Aspartate amino transferase
(ASAT)/cell number
D Exponential Yes Human Density +
Elutriation
Jansen et al., 1986
AMP deaminase/mg Hb D Exponential/constant Yes Rabbit In vivo
biotinylation
Dale and Norenberg, 1989
MARKERS OF SENESCENCE
Glutathione reductase
(GR)/cell number
D Linear Yes Human Density +
Elutriation
Jansen et al., 1986
HbA1c (glycated Hb)
fraction/Whole Hb
I Linear – Human Biotinylation Willekens et al., 2003; Cohen
et al., 2008
Ratio of content of band
4.1a/4.1b/mg protein
D Linear Yes Many Density Mueller et al., 1987; Inaba
and Maede, 1988
Acetylcholinesterase
units/mg Hb
D Linear Yes Human Density Cohen et al., 1976
Creatine/cell number D Exponential Yes Human Density Fehr and Knob, 1979
Changes in activity: I, increase and D, decrease; Phase a, reticulocytes mainly; phase b, mature RBC; Hb, hemoglobin; density, fractionation on the density gradient.
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migrate to their actual density (Clark, 1985; Lutz et al., 1992).
Aside of density separation aging RBC have been separated from
each other by size, using counterflow centrifugation (elutriation),
a method that offers a limited yield of separated cells and may
best be combined with a preceding density centrifugation (Bosch
et al., 1992).
THE CHANGES OCCURRING IN VIVO, WHEN LABELED RBC
ARE RE-INTRODUCED INTO THE CIRCULATION
By far the most direct method to study in vivo aging of RBC
is their biotinylation by N-hydroxysuccinimide-biotin and ana-
lyzing the properties of the biotinylated RBC during their life
span in circulation by collecting the labeled RBC on avidin at
various times after injection (Suzuki and Dale, 1987; Christian
et al., 1993). The biotin derivative was dissolved in DMSO and a
diluted sample was injected intravenously into dogs after bleeding
to enhance the portion of young RBC in the labeled popula-
tion (Christian et al., 1993). In humans bleeding was not an
option and biotinylation had to occur in vitro. Hence, the frac-
tion of labeled RBC was rather small toward the end of the
in vivo survival study by 110–126 days (Franco et al., 2013).
Nevertheless, it has been possible for the first time to demon-
strate that all in vivo aged, biotinylated human RBC that were
recovered 126 days post injection had increased amounts of
membrane-bound IgG, but were not enriched at all in exo-
plasmically exposed PS (Franco et al., 2013). Similar findings
have earlier been reported for dogs having a similar RBC sur-
vival time as humans. By 110 days biotinylated RBC carried 7
fold higher amounts of autologous IgG per RBC and massively
increased amounts of membrane bound globin (Rettig et al.,
1999). Unexpectedly, the density of biotinylated RBC increased
primarily during the first 4 weeks of in vivo aging, but not or
less thereafter as revealed by using preformed density gradients
(Franco et al., 2013). Similar results were obtained earlier for
biotinylated sickle RBC (Franco et al., 1998). The authors blame
the density-separation technique for the unexpected results and
suggest that density centrifugation should be combined with
elutriation to achieve a better separation according to cell age.
However, it cannot be excluded that ex vivo biotinylation of
RBC in diluted DMSO and several washes had altered the prop-
erties of RBC that were not leucocyte-depleted. Nevertheless,
analogous results on aging dog RBC confirm the unexpected
finding. Dog RBC were in vivo biotinylated and revealed dur-
ing survival signs of an accelerated aging in so far as a classi-
cal cell age parameter, the ratio of the band 4.1a/4.1b content
had reached its maximum (full deamidation) in the biotiny-
lated RBC portion long before the biotinylated RBC had reached
their full survival time (Rettig et al., 1999). It may be possi-
ble that the findings were real, implying that a small fraction of
aging RBC underwent a terminal density reversal by taking up
sodium ions and water, as first described by Bookchin (Bookchin
et al., 2000) and discussed in detail by Lew and Tiffert (2013).
More studies are needed to clarify whether the terminal density
reversal is induced by DMSO or the washes without white cell
removal.
In the following chapters we address several parameters
delineating age-related changes in healthy human RBC. Among
them are oxidative stress, changes in cell volume and density,
vesiculation, band 3 clustering, and binding of NAbs.
THE ROLE OF OXIDATIVE STRESS IN RED CELL CLEARANCE
Cell aging is intimately related to the changes in the balance
between production of pro-oxidants and their removal by anti-
oxidative enzymes and scavengers to which reduced glutathione
(GSH), NADH, NADPH, and ascorbate belong. Gradual accu-
mulation of irreversibly oxidized and denatured proteins, in par-
ticular hemoglobin, occurs with ageing (Rifkind and Nagababu,
2013). Changes in activity of multiple enzymes, loss or reor-
ganization of several proteins as well as alterations in plasma
membrane lipid composition occur gradually in RBC over 120
days in circulation and are mainly caused by oxidative modifica-
tions. De novo synthesis of both proteins and lipids is absent in
mature RBC. Accordingly, oxidized and denatured proteins accu-
mulate in aging RBC and even more so because aging RBC lose
free radical scavengers (Bartosz, 1981).
ANTIOXIDANT CAPACITY OF RBC
Among the antioxidants which prevent oxidation of protein thi-
ols are GSH, NADH, and NADPH. Of these three compounds
the half-cell redox potential based on the ratio of GSH to oxi-
dized glutathione (GSSG) is postulated to be a reliable marker
of the intracellular redox state (Schafer and Buettner, 2001).
Reduced glutathione does not cross the plasma membrane pas-
sively and de novo synthesis of GSH is the only source of GSH in
RBC. Facilitated unidirectional efflux of GSSG from the RBC is
mediated by an ATP(GTP)-dependent transporter (RLIP76) and
multidrug resistance protein 1 (MRP1) (Srivastava and Beutler,
1969; Bobrowska-Hagerstrand et al., 2001; Sharma et al., 2001).
The ability of RBC to synthesize GSH, the presence of enzymes
involved in GSH synthesis and GSSG formation (Figure 1) have
been demonstrated in RBC lysates (Sass, 1968). Two substrates
for glutathione synthesis, cysteine and glycine, are transported
into the cells whereas glutamate is produced from aspartate and
alanine by aspartate aminotransferase and alanine aminotrans-
ferase. As follows from the scheme in Figure 1 de novo synthesis
of glutathione requires ATP and its reduction from GSSG to GSH
requires NADPH.
The intracellular non-protein thiol levels, of which GSH is
the major species, decrease substantially during the transforma-
tion of reticulocytes to mature RBC, but their concentration
remains rather constant thereafter (Magnani et al., 1983; Piccinini
et al., 1995). In all these studies the average intracellular GSH
and GSSG concentrations were assessed without discriminat-
ing between the ratio of GSH to GSSG in the pre-membrane
pool and that in the cytosolic core. Since the oxidative stress in
aging RBC is particularly severe at the membrane, these mea-
surements may not precisely reflect the aging-related shift in the
redox state. The activity of γ-glutamylcysteine synthetase and that
of GSH synthetase, two major enzymes involved in glutathione
synthesis (Figure 1), remain unchanged in RBC with increasing
density (Minnich et al., 1971) and get suppressed only in the cells
showing the highest density on the Stractan gradient (Piccinini
et al., 1995). The activities of key glycolytic enzymes hexoki-
nase, pyruvate kinase, and glucose-6-phosphate dehydrogenase,
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FIGURE 1 | Glutathione production and turnover in RBC. Schematically
presented are substrate delivery, glutathione synthesis, and glutathione
handling in RBC. EMP stands for Embden-Meyerhof pathway (anaerobic
glycolysis). HPS denotes hexose monophosphate shunt (pentose phosphate
pathway). G-6P and 6 PG stand for glucose-6-phosphate and
6-phosphogluconolacton respectively. Glu, Gln, Gly, Cys, Ala, and Asp stand
for glutamate, glutamine, glycine, cysteine, alanine, and aspartate
respectively.
as well as that of aspartate aminotransferase which provides
glutamate for GSH synthesis, were the highest in the low den-
sity fraction and progressively decreased with an increase in
red cell density [(Fornaini et al., 1985; Jansen et al., 1986) and
Table 1].
Glucose transport across the RBC membrane decreases with
cell age (Bosman and Kay, 1990). Young (least dense) RBCmetab-
olize 2.5 timesmore glucose than old ones. On the other hand, the
amount of glucose utilized via the hexose monophosphate shunt
does not show any age dependence. Intracellular ATP levels drop
by 30–40% following the down-regulation of Embden-Meyerhof
(EMP) pathway (Cohen et al., 1976; Magnani et al., 1983), con-
tributing to a shortage of GSH production in the densest RBC
fraction.
RBC possess an efficient enzymatic machinery to process and
detoxify reactive oxygen and nitrogen species, including superox-
ide dismutase (SOD1), catalase, peroxidases as well as glutathione
peroxidase, peroxiredoxin 2 and glutaredoxin 1, which reverse
oxidative thiol modifications on proteins and preserve enzyme
activities from oxidative inactivation. The activities of some of
these anti-oxidants, such as SOD1 and catalase decline during
aging (Bartosz et al., 1978; Bartosz, 1980, 1981; Bartkowiak et al.,
1983). Even extracellular SOD isozymes, including mitochon-
drial SOD2 (presumably from the endothelial cells), participate
in detoxifying free radicals that cause RBC oxidation, as SOD2-
deficient animals presented with higher rates of hemoglobin
oxidation than controls (Mohanty et al., 2013). Further studies
using knockout animals indicate that at least in rodents perox-
iredoxin 2 and glutaredoxin 1 are the major enzymes detoxifying
endogenous H2O2 in RBC (Lee et al., 2003; Johnson et al.,
2010). Catalase on the contrary takes over detoxification of H2O2
produced externally (Johnson et al., 2010). RBC age-dependent
changes in peroxiredoxin 2 and glutaredoxin 1 activities have not
been studied yet.
SOURCES OF OXIDATIVE EQUIVALENTS IN SENESCENT RBC
Cell age-related oxidation is largely a membrane-localized event,
because free radical generators are compartmentalized. Most of
them are localized within the membrane or are attached to mem-
brane proteins from the cytosolic side, whereas enzymes detoxi-
fying them as well as low molecular weight thiols are randomly
distributed within the cytosol.
Auto-oxidation of hemoglobin is considered to be the major
source of superoxide anion production in senescent RBC.
Reduction of dioxygen to O−2 is associated with the genera-
tion of methemoglobin. Ferric iron of methemoglobin is then
reduced to the ferrous state by hemoglobin reductase which
uses NADH as a substrate. The methemoglobin concentration
was shown to increase linearly with increasing RBC density
(Imanishi et al., 1985; Rettig et al., 1999). In vitro studies of
the hemoglobin auto-oxidation revealed that the reaction is slow
(k = 0.0115 h−1) under normoxic conditions (Nagababu et al.,
2002), but is facilitated dramatically upon partial deoxygenation
(Abugo and Rifkind, 1994) and is maximal at pO2 of 1.33 kPa
(Rifkind et al., 2004). Deoxyhemoglobin readily binds to the
cytosolic domain of band 3 (Walder et al., 1984). This suggests
that the levels of deoxyhemoglobin at the membrane surface
exceed those in the cytosol. Furthermore, aging of RBC is associ-
ated with an increase in spectrin-hemoglobin complexes (Snyder
et al., 1983) which contribute to an increased rigidigty of senes-
cent RBC in dense fractions (Fortier et al., 1988). Accumulation
of hemoglobin at the membrane surface and its auto-oxidation
results in production of superoxide anion. Two further classes of
enzymes which contribute to superoxide production are NADPH
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oxidases of which several isoforms are present in RBC (George
et al., 2013) and endothelial NO synthase which is present in
human and mouse RBC (Kleinbongard et al., 2006) and produces
O−2 when L-arginine levels are low (Mihov et al., 2009).
Superoxide anion has a half-life of 10−6 s and undergoes
a number of transformations depending on the availability of
NO, superoxide dismutase (SOD), and H2O2. Interaction of
O−2 with NO (k = 4–6109 M−1s−1) is four orders of magni-
tude faster than dismutation of O−2 to H2O2 catalyzed by SOD
(k = 2105 M−1s−1). Thus, formation of peroxynitrite (ONOO−)
from O−2 dominates over the transformation of O
−
2 to H2O2 cat-
alyzed by superoxide dismutase if NO is available (Borges-Alvarez
et al., 2012). Peroxynitrite generated in this manner is believed to
be a potent mediator of oxidative stress in RBC (Minetti et al.,
2008; Rifkind and Nagababu, 2013). However, aging of RBC is
not associated with an accumulation of nitrated tyrosine, the
product of peroxynitrite reacting with membrane proteins or
hemoglobin (Kikugawa et al., 2000). It is suggested that perox-
ynitrite production in circulating RBC is minimal due to the
low abundance of deoxyhemoglobin (Winslow and Intaglietta,
2008). Thus, the importance of peroxynitrite as a mediator of
oxidative stress in aging RBC remains questionable. NO may be
viewed as a scavenger of superoxide radicals and therefore as a
member of the antioxidative defense system. This defense system
is challenged particularly under hypoxic conditions when par-
tially oxygenated hemoglobin prone to auto-oxidation is formed.
Deoxygenated hemoglobin has been shown to function as nitrite
reductase transforming nitrite to NO being itself oxidized to
methemoglobin (Gladwin and Kim-Shapiro, 2008).
Endogenous hydrogen peroxide formed by a SOD1-catalysed
reaction as well as exogenous H2O2, diffusing into RBC from
plasma, may be detoxified by catalase or peroxidase. However,
when ferrous or ferric ions are available they catalyze reactions
known as Haber-Weiss cycle in which hydroxyl radicals (HO)
are formed. The hydroxyl radical has a half-life of 10−9 s and
is extremely reactive and pro-oxidative. Iron ions are becom-
ing accessible in the pre-membrane space during the process
of oxidation and denaturation of membrane-bound hemoglobin
occurring with aging of RBC (Low et al., 1985). Hemichrome
accumulation and binding to the cytosolic domain of band 3
protein is a hallmark of RBC senescence.
TARGETS OF OXIDANTS
RBC are one of the models of choice to monitor the effects of
oxidants on proteins and lipids [e.g., Di Simplicio et al., 1998;
Minetti et al., 2008]. However, relatively few studies refer to the
monitoring of thiol modifications during ageing of RBC in vivo
in healthy humans.
Hemoglobin, being the most abundant (98% of total protein
content) protein in RBC, is the main generator of reactive oxygen
species, the main target of oxidative damage and also a scavenger
of free radicals. Detoxification of free radicals by hemoglobin is
associated with the production of met-hemoglobin and oxida-
tion of a single cysteine residue present in position 93 of the
beta chain (Vitturi et al., 2013). The generated methemoglobin
releases iron as Fe+3 in a chelatable form that can further prop-
agate oxidative damage and induce binding of autologous IgG.
Ferrali et al. synthesized an aromatic iron-chelator and applied it
to mice in which oxidative damage and iron release were induced
by a phenylhydrazine treatment. The RBC from animals treated
with the chelator were protected from oxidative damage and from
binding of autologous IgG (Ferrali et al., 2000).
Band 3 protein is also a target of oxidation, particularly when it
has formed complexes with oxidized and denatured hemoglobin,
hemichrome (Mannu et al., 1995). Accumulation of membrane-
associated oxidized hemoglobin is considered to be one of the
major (but not the only) trigger of band 3 cluster formation (Low
et al., 1985; Schlüter and Drenckhahn, 1986). In addition, oxi-
dation is a trigger for activation of src tyrosine kinases (Mallozzi
et al., 2001) and inhibition of tyrosine phosphatases (Zipser et al.,
2002), resulting in a cumulative tyrosine hyperphosphorylation
of membrane target proteins. The src kinases including syk and
lyn kinases phosphorylate tyrosines 8 and 21 of the cytosolic
domain of the band 3 protein, thereby facilitating formation of
high-molecular-mass band 3 aggregates (Pantaleo et al., 2009).
Oxidation and poor glycosylation of band 3 further facilitates
clustering of this protein (Pantaleo et al., 2009). Its tyrosine phos-
phorylation markedly reduces the affinity of band 3 to ankyrin,
causing destabilization of the band 3-cytoskeleton interaction,
increases the lateral mobility of band 3 within the membrane and
induces vesiculation (Ferru et al., 2011). Both srk kinases syk and
lyn and the tyrosine phosphatase PTP1B are redox-sensitive, be
it because they possess cysteine residues in the kinase domains or
indirectly, because their activity is controlled by the redox- and
calcium-sensitive phosphorylation steps mediated in particular
by protein kinase C alpha (Bordin et al., 2005; Knock and Ward,
2011).
CHANGES IN ACTIVITY OF ION TRANSPORTER DURING RBC
SENESCENCE
Transformation from reticulocytes to mature RBC and ageing of
the latter is associated with radical re-organizations of the plasma
membrane. Reduction in membrane surface by means of exocy-
tosis duringmaturation of reticulocytes enables the cells to reduce
or completely eliminate a number of receptors and ion trans-
porters which play an active role in differentiation of erythroid
precursor cells and are no longer required bymature RBC. Among
the most well-known is the transferrin receptor. The number of
copies per cell of Na,K-ATPase, Na/glycine transporter (Blostein
and Grafova, 1987), nucleoside transporter, and K-Cl cotrans-
porter (Canessa et al., 1987; Ellory et al., 1991) is reduced and
renders the cell less energy-demanding and more stable.
Several ion transporters that are not extruded in exo-
somes undergo an age-dependent inactivation. The activity
of the Gardos channel is reduced with ageing (Tiffert et al.,
2007). Similarly, the number of copies of N-methyl D-aspartate
(NMDA) receptors, non-selective cation channels mediating
Ca2+ uptake into RBC, also decreases with cell age (Makhro
et al., 2013). Plasma membrane Ca2+ pump was also reported to
decline with cell age (Lucas et al., 1988; Samaja et al., 1989).
These conclusions may not necessarily apply to all cells within
the light, medium or dense fractions of RBC, but to a major-
ity of them. Recently extreme heterogeneity in responses of RBC
to glutamate and homocysteic acid (Makhro et al., 2010, 2013),
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prostaglandin E2 (Kaestner et al., 2004), LPA (Wagner-Britz et al.,
2013) has been recognized. This heterogeneity results from the
inter-cellular variability in abundance of the corresponding ion
transport pathways [NMDA receptors, voltage-gated Ca2+ chan-
nels (Cav2.1), and LPA receptors] in RBC of healthy humans
(Makhro et al., 2013; Wagner-Britz et al., 2013).
In the following section the impact of vesicle release on RBC
aging will be discussed. This process of membrane loss also
contributes to the increase in density of senescent cells.
RELEASE OF MICROVESICLES AND NANOVESICLES FROM
AGING RBC
It is known for many years that senescent RBC are smaller,
denser than young cells and have lost membrane and
hemoglobin. Nevertheless, many investigators have quanti-
fied N-acetylneuraminic acid (sialic acid) per young and per old
RBC and then claimed that sialic acid decreased with cell age and
the exposed remainder may act as a senescent cell marker, capable
to trigger/mediate their selective removal (Gutowski et al., 1991;
Bratosin et al., 1995). When the content of sialic acid was referred
to a measure of the number of integral membrane proteins on
young and old RBC, it was with ± 1.5% the same (Lutz and
Fehr, 1979) and the cellular electrophoretic mobility remained
unchanged during RBC aging (Luner et al., 1977). Despite the
electrophoretic mobility remains unchanged, aging RBC loose a
substantial portion of their membrane and content in form of
microvesicles [reviewed in references Greenwalt (2006), Tissot
et al. (2010)]. For a long time microvesicles were not in the focus
of research, because those that are released in vivo are rapidly
cleared and their relation to those from stored RBC was unclear.
This situation has drastically changed since it has become obvious
that the microvesicles from stored RBC have deleterious effects
in transfused patients [for a review see Tissot et al. (2010)]. One
of the deleterious effects comes from priming the respiratory
burst of neutrophils (Jank and Salzer, 2011), which was, however,
far more pronounced by microvesicles from RBC that were not
leucocyte-depleted (Cardo et al., 2008).
The shedding of microvesicles from in vivo aging RBC was first
illustrated by Dumaswala and Greenwalt (1984). By that time two
types of in vitro RBC vesiculations had already been discovered
as laboratory phenomena: Allan and coworkers had characterized
vesicles released from RBC incubated with Ca2+ and ionophore
(Allan and Michell, 1977) and Lutz and coworkers had stud-
ied vesicles released from ATP-depleted RBC (Lutz et al., 1977).
Both types of vesicles contain hemoglobin and their membranes
are enriched about 2-fold in exoplasmic acetylcholinesterase, lack
spectrin and ankyin, but retain the integral membrane pro-
teins band 3 and glycophorin to about 50%. Generation of
microvesicles from stored RBC was also described in the 70s for
storage in ACD (acid-citrate-dextrose) by Rumsby et al. (1977).
These authors noted that stored RBC release hemoglobin-filled
microvesicles that are depleted of spectrin, but contain integral
membrane proteins. More recent data on the microvesicle release
from stored and from Ca2+-loaded RBC that were leucocyte-
depleted, have yielded the following insights. At the onset of
RBC storage the releasedmicrovesicles differ in composition from
those released from Ca2+-loaded RBC. After prolonged storage
(beyond 21 days), when the ATP-content of stored RBC decreases
rapidly, the total amount of released vesicular proteins increases
exponentially, reaching 10 times the amount by 50 days as com-
pared to 14 days of storage and their composition becomes
comparable to that of Ca2+-induced vesicles (Salzer et al., 2008).
It is possible that this late change in amount and properties
of microvesicles from stored RBC may be the major reason for
why long stored blood units were primarily responsible for the
deleterious effects in transfused patients.
RBC shrinkage and echinocytosis precede the release of
microvesicles. It is known that budding and the release of
microvesicles from RBC incubated with Ca2+ and ionophore are
induced by the formation of diacylglycerol (Allan and Michell,
1977). Microvesicle generation from ATP-depleted RBC also
correlates with the breakdown of polyphosphoinositides to dia-
cylglycerol on the inner monolayer (Müller et al., 1981). The
diffusible diacylglycerol partitions into the outer monolayer and
thereby contributes to membrane budding. Nevertheless, mem-
brane budding and shedding of microvesicles yet require other
changes, because 10mM EDTA inhibited microvesicle release by
75% without affecting diacylglycerol production (Müller et al.,
1981). Indeed, membrane budding is further dependent on exo-
plasmic exposure of phosphatidylserine (PS), a negatively charged
phospholipid that normally is exclusively localized on the inner
monolayer. Its exposure on the outer monolayer depends on acti-
vation of the scramblase by intracellular Ca2+, which is induced
by ionophore (Nguyen et al., 2011) or by lysophosphatidic acid
during RBC storage, but less upon prestorage leukodepletion
(Nagura et al., 2013). It was further noted that prolonged stor-
age of leucocyte-depleted RBC increases the susceptibility of RBC
to stress-induced loss of phospholipid asymmetry. The effect was
most pronounced for old RBC when experimentally evoked by a
hyperosmotic shock, such that PS exposure increased 10-fold by
4 weeks storage and more so in old RBC (Bosman et al., 2011).
Strong arguments in favor of PS exposure being required for
microvesicle release come from (1) a bleeding disorder, the Scott
syndrome, where RBC neither translocate PS across the mem-
brane nor release microvesicles (Bevers et al., 1992) and (2) the
finding that a specific inhibitor of the scramblase (R5421) inhibits
both PS exposure and microvesicle release to more than 50%
(Gonzalez et al., 2009).
The regions on RBC that become enriched in diacylglyc-
erol and PS are associated with lipid rafts. Lipid rafts are
microdomains in the plasmamembrane, rich in cholesterol and
glycosphingolipids and contain unique proteins that differ in the
two types of rafts known to exist in RBC. One type contains
primarily stomatin and the flotillins (flotillin1 and 2). While
the palmitoylated, hydrophobic stomatin is an integral mem-
brane protein, the flotillins are peripheral membrane proteins
with hydrophobic domains capable of associating with the bilayer
(Salzer et al., 2002, 2008). Microvesicles (160 nm diameter) from
RBC stored for more than 20 days (Kriebardis et al., 2008) and
from Ca2+ loaded RBC (Salzer et al., 2002) contain band 3,
are enriched in acetylcholinesterase and in stomatin (2-fold as
compared to the original membrane), but threefold depleted of
flotillin 2 that remains in the residual RBC membrane (Salzer
et al., 2008). The thrombogenic activity of microvesicles released
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from stored RBC or from Ca2+ and ionophore treated RBC is
comparable (Salzer et al., 2008). Microvesicles from long stored
RBC contain heavily aggregated hemoglobin, band 3 aggregates
and increasing amounts of autologous IgG (Kriebardis et al.,
2008), while the residual RBC reveal a decrease in band 3 con-
tent, but yet a substantial increase in bound IgG (Kriebardis et al.,
2007). Both types of microvesicles also contain small amounts
of synexin and sorcin. The two peripheral membrane proteins,
synexin and sorcin are predominantly associated with the second
type of lipid raft in RBC and become the major proteins in the
Ca2+-induced nanovesicles (60 nm diameter) (Salzer et al., 2002).
Nanovesicles lack band 3, contain little stomatin, but are highly
enriched in the two peripheral proteins synexin and sorcin, two
proteins that were not known to exist in RBC (Salzer et al., 2002).
Synexin is an annexin-like protein and binds in a Ca2+ depen-
dent manner to sorcin and the cytoplasmic side of the budding
membrane of nanovesicles. In other cells the two proteins play
important roles in fusion of lamellar bodies (Sen et al., 1997).
The sequence of events in microvesicle and nanovesicle for-
mation and release illustrates that cellular aging as evident from
increasing amounts of oxidized hemoglobin, aggregated band 3
protein and surface-bound IgG appears to induce an entrap-
ment of these irreversible endproducts in lipid raft-containing
microvesicles that are rapidly cleared. The rapid clearance of
these microvesicles occurs most likely by Kupfer cells and other
macrophages via recognition of exposed PS, as established in
an animal model using rats (Willekens et al., 2005). The selec-
tive release of vesicles containing aggregated band 3 with bound
naturally occurring antibodies evidently prevents a premature
recognition of the aging RBC by phagocytes.
NATURALLY OCCURRING ANTI-BAND 3 ANTIBODIES AND
COMPLEMENT IN CLEARANCE OF SENESCENT HUMAN RBC
When Kay published her first paper on the “mechanism of
removal of senescent cells by human macrophages” in 1975 it
was the first contribution that addressed the selective clearance of
in vivo aged human RBC (Kay, 1975). Senescent but not young
RBC, as obtained by density separation, are phagocytosed by
macrophages, while phagocytosis of in vitro aged RBC requires
opsonization with autologous IgG. IgG eluted from senescent
RBC induces phagocytosis of in vitro stored young RBC (Kay,
1978). These findings demonstrated that “opsonization of aging
RBC by autologous IgG” represents the effect of “beneficial
autoantibodies,” of “physiologic autoantibodies” that were also
called natural antibodies or naturally occurring (auto)antibodies
(NAbs). NAbs with beneficial roles had already been observed in
1942 (Kidd and Friedewald, 1942), but went almost unnoticed
during the rapid development of classical immunology in the 60
and 70 s. This situation changed in the early 80 s with the descrip-
tion of NAbs against nine common human antigens (Guilbert
et al., 1982) and the availability of the immunoblotting tech-
nique to visualize binding of whole IgG to individual membrane
proteins (Towbin et al., 1979) and to embark on the affinity purifi-
cation of NAbs to RBCmembrane proteins like spectrin (Lutz and
Wipf, 1982) and band 3 (Lutz et al., 1984).
In trying to identify the antigen exposed on aged RBC Kay car-
ried out affinity purification of RBC proteins on immobilized IgG
from senescent RBC and reported that this IgG NAb binds to a
62 kDa protein of old RBC (Kay, 1981). At the same time Lutz had
evidence for band 3 oligomers to represent the antigen to which
autologous IgG binds to (Lutz, 1981). The immune precipitate
obtained with second antibody from detergent extracts of 125I-
iodinated RBC contained material at 100 and 200 kDa and shared
iodinated peptide maps with that of band 3 protein. Analogous
precipitates from chymotrypsin-treated RBC yielded primarily a
labeled 65 kDa fragment, implying that the intact antigen was
band 3 (the two chymotryptic fragments of band 3 were ascribed
the MW of 65 and 38 kDa to the carbohydrate-containing frag-
ment, later with sequence data available these fragments were
named 55 and 35 kDa fragment). Lutz and coworkers could estab-
lish that the antigenic site preexists in band 3 protein, but becomes
accessible for NAb binding upon band 3 clusterization e.g., on
spectrin-free vesicles in which band 3 is laterally mobile. This
overview was concluded by suggesting that also in Kay’s experi-
ments the RBC-specific NAb may have bound to band 3/band 3
aggregates, but ended up in a 62 kDa fragment because of pro-
teolysis (Lutz, 1981). The above mentioned data could not be
published in a prestigious journal, because the existence of anti-
band 3 NAbs had not yet been proven, though immunoblots with
whole IgG revealed not only binding to both spectrin band 1
and 2 but also to band 3 (Lutz and Wipf, 1982). Eventually the
entire information was published in pieces: Binding of autolo-
gous IgG was 14 times higher to spectrin-free vesicles than to
ATP-maintaining RBC (Müller and Lutz, 1983), implying that
NAb binding increases with oligomerization of integral mem-
brane proteins. A detailed study of the glycoprotein topology
on human RBC after an extensive aminogroup supplementa-
tion further showed that the 106 band 3 molecules exist either
as monomers or non-crosslinkable dimers of which the cross-
linkable portion is minute, but increases at a confidence level
of 0.06 by 0.4% from young to senescent cells (Schweizer et al.,
1982). By leucocyte-depletion of RBC, by inhibiting proteases
with phenylmethyl sulfonyl chloride (PMSF), by surface-125I -
iodinating young and old RBC, by extraction with Triton and
addition of a second antibody it was demonstrated that pre-
existing immune complexes contained band 3 monomers and
oligomers in samples from old but not young RBC (Lutz and
Stringaro-Wipf, 1983). Furthermore, preincubation of extracts
from young RBC with autologous IgG resulted in immunopre-
cipitation of band 3, again suggesting the preexistence of antigenic
sites in young RBC. Finally, anti-band 3 NAbs were purified from
IgG of individuals and pooled IgG (Sandoglobulin) and charac-
terized (Lutz et al., 1984). The antigenic site of anti-band 3 NAbs
is located within the 65 kDa, but not the 38 kDa chymotryptic
fragment of band 3 and antigenic band 3 protein is equally present
on young and old RBC, implying that exposure requires an altered
accessibility rather than an enzymatic generation of antigenic sites
as suggested by Kay (Kay and Goodman, 1984). Indeed binding of
purified anti-band 3 NAbs was about 10 times higher to band 3
oligomers than to monomers (Lutz et al., 1984).
In 1983 Kay followed the initial observation of Lutz et al.
and reported that the senescent cell antigen is immunologically
related to band 3, because not only the 62 kDa protein, but also
intact band 3 inhibited phagocytosis of RBC incubated with IgG
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eluted from senescent RBC (Kay et al., 1983). In contrast to earlier
work from her group, RBC studied in this paper were leucocyte-
depleted and proteases inhibited in extracts. Correspondingly the
stained band pattern of RBC ghosts did not reveal the 62 kDa
fragment [for comparison see reference Kay (1981)]. The anti-
senescent cell IgG was said to bind to both chymotryptic frag-
ments from band 3, though the blot showed almost exclusive
binding to the larger chymotryptic fragment (Kay, 1984). While
this disagreement on anti-band 3 specificity continued (Kay et al.,
1988; Kay, 1992), others built on the findings of Lutz et al. and
extended their own studies on cell age dependent hemichrome
binding to band 3 protein (Waugh and Low, 1985) by asking
whether the clustering of band 3, which is induced by dena-
tured hemoglobin might also promote binding of autologous IgG
(Low et al., 1985). Indeed, oxidative damage induced by a phenyl-
hydrazine treatment of RBC, known to result in hemichromes,
greatly stimulated binding of autologous IgG and IgG binding
colocalized with band 3 protein (Low et al., 1985). Sorette and
Clark raised their doubts on the treatment with phenylhydrazine
to simulate cell aging and showed that the highest IgG binding
was to RBC with membrane lesions (Sorette and Clark, 1991).
Drenckhahn a former collaborator of Low continued their joint
studies and demonstrated that RBC of patients with unstable,
oxidation-sensitive forms of hemoglobin (Heinz body anemia,
hemoglobin Köln, and sickle cell anemia) revealed a co-clustering
of denatured hemoglobin, of band 3 protein and of RBC-bound
immunoglobulins, without having to pretreat RBCwith an exoge-
nous oxidizing agent (Schlüter and Drenckhahn, 1986). Low’s
group then isolated the densest human RBC and showed it con-
tained 6 timesmoremembrane bound hemichromes and 10 times
more surface-bound autologous IgG than other RBC fractions of
lower density (Kannan et al., 1991). They even managed to enrich
the microscopic aggregates comprised of hemichromes, band 3
and spectrin, constituting 0.09% of the membrane protein, but
carrying 55% of the total cell-bound IgG.
On a meeting in Israel Arese and Lutz got to know each other
and decided to collaborate by using the phagocytosis assay with
diamide-treated human RBC developed in Arese’s lab (Bussolino
et al., 1987) to investigate the functional properties of puri-
fied anti-band 3 NAbs. Anti-band 3 NAbs purified from pooled
human IgG (Sandoglobulin) bound to SS group-containing band
3 oligomers and stimulated phagocytosis of diamide-treated RBC
maximally at 10–20μg/ml (Lutz et al., 1987). Largely unexpected
was that efficient phagocytosis required C3b deposition, unless
anti-band 3 NAbs were added at 20–100 times the physiological
concentration. C3b binding to diamide-treated RBC was about
two orders of magnitude higher than that of anti-band 3 NAbs
and even occurred under alternative complement pathway con-
ditions (Lutz et al., 1987). Likewise, senescent RBC having a
five-fold lower creatine content than young RBC not only con-
tained significantly more IgG, but also SDS-resistant complexes
comprised of IgG and C3b as verified by immunoblotting with
anti-IgG and anti-C3c (Lutz et al., 1988). Then, by quantify-
ing the binding of labeled anti-band 3 NAbs to C3 it became
obvious that anti-band 3 NAbs have a unique affinity for C3,
while anti-spectrin NAbs not (Lutz et al., 1989). The weak affin-
ity for C3 (2–3 × 105 l/mol) at a site independent of the antigen
binding domain is about 100 times higher than that of whole
IgG, known to have a weak affinity for C3 (Lutz et al., 1993b).
This affinity for C3 is responsible for the preferential formation
of C3b-IgG and C3b2-IgG complexes during complement acti-
vation (Lutz et al., 1993c). Years later Jelezarova et al. verified
that all such complexes contain dimeric C3b (C3b2-IgG), ester-
bonded to one heavy chain of IgG (Jelezarova et al., 2003). It is
the dimeric C3b within these complexes that renders them effi-
cient activators of the alternative complement pathway. Thus, the
ability of certain low affinity NAbs, like anti-band 3, to form
such complexes during complement activation renders them far
more efficient opsonins than judged from the number of bound
antibody. Frank and collaborators had earlier found that certain
induced IgG antibodies to bacteria also formed covalent com-
plexes with C3b (C3b-IgG), which rendered these IgG molecules
3–4 fold more effective in stimulating complement deposition
(Joiner et al., 1985).
To clarify the homeostatic role of purified anti-band 3 NAbs
the survival of untreated and diamide-treated RBC was investi-
gated in guinea pigs. In normal, but not in C3-deficient guinea
pigs human anti-band 3 NAb binding significantly accelerated
the clearance of diamide-treated guinea pig RBC (Giger et al.,
1995). Likewise, a pretreatment of the animals with 200μg of
human band 3 protein slowed down the clearance of diamide-
treated guinea pig RBC to the extent observed without anti-band
3 NAbs. In support of the role of complement Turrini et al.
used either ZnCl2, acridine orange or melittin to cluster inte-
gral membrane proteins and determined binding of autologous
IgG, complement C3c and quantified phagocytosis. The authors
could confirm and extend the observations from the group of
Lutz in so far as the clustering agent was only effective upon
subsequent crosslinking of aggregated band 3 protein and only
then induced binding of autologous IgG, deposition of C3c and
phagocytosis (Turrini et al., 1991). IgG eluted following disag-
gregation of band 3 oligomers bound almost exclusively to band
3, its dimer and oligomers (Turrini et al., 1993). Disulfide-cross-
linked band 3 dimers are indeed the minimal band 3 aggregates
with enhanced affinity for anti-band 3 NAbs (Turrini et al.,
1994). Similar conclusions were drawn by Beppu et al., using
three different approaches to oxidize human RBC. All pretreat-
ments increased binding of autologous IgG as well as of purified
anti-band 3 NAbs and binding was inhibited by purified band 3
protein or by restoration of the protein SH groups (Beppu et al.,
1990).
Oxidation or a treatment with a clustering agent and
cross-linking of the generated clusters evidently simulates the
prerequisites for clearance of RBC, but does not explain how
band 3 clusters are formed during in vivo aging. Several authors
have focused on the potential role of superoxide and NO, known
to form peroxynitrite that induces lipid peroxidation and oxi-
dizes hemoglobin to methemoglobin (Matarrese et al., 2005).
Oxidative damage by peroxynitrite induces tyrosine phospho-
rylation of band 3 protein by several orders of magnitude and
this phosphorylation enables the dissociation of band 3 from
the spectrin-actin skeleton by lowering its affinity for ankyrin,
whereby its cross-linkability and in plane diffusion are ele-
vated (Ferru et al., 2011). Despite peroxynitrite can induce the
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oxidation of hemoglobin, can provide the prerequisite for band
3 protein oligomerization and can enable exoplasmic PS expo-
sure, all these alterations are reversed by reactivation of glycolysis
(Pietraforte et al., 2007). This implies that damage is minimal
in aging RBC as long as ATP levels are maintained. Hence, per-
oxynitrite may contribute to oxidative damage in microvesicles,
but not in aging RBC that maintain their ATP concentration at
a high level and do not expose PS exoplasmically. An elegant
recent report has finally brought the answer. Arashiki et al. have
shown that efficient binding of methemoglobin to band 3 protein,
requires a preceding peroxidation of the cytoplasmic portion of
band 3 protein (Arashiki et al., 2013). Peroxidation of the cyto-
plasmic portion of band 3 protein results in carbonylation of
this domain and this in turn enhances methemoglobin binding
5–7 fold. Bound methemoglobin then induces a conformational
change which displaces ankyrin and gives rise to band 3 cluster
formation.
ANTI-BAND 3 NAbs AND INDUCED ANTI-LACTOFERRIN
ANTIBODIES
Anti-band 3 NAbs, as isolated from plasma of healthy blood
donors with blood group O or from Sandoglobulin bound to
band 3 and exclusively to the 68/55 kDa chymotryptic frag-
ment of band 3, but not to the carbohydrate-containing,
38/35 kDa fragment (Lutz et al., 1984). Eight years later Beppu
reported that their anti-band 3 NAbs bind to the sialylated
N-acetyllactosaminyl carbohydrate group localized within the
38 kDa fragment of band 3 (Beppu et al., 1992; Ando et al.,
1994). Lutz et al. reinvestigated the specificity of anti-band 3NAbs
purified from pooled human IgG as found in Sandoglobulin.
Anti-band 3 NAbs as prepared originally bound to band 3 and
weakly to the cytoskeletal proteins band 4.2, 5 and spectrin. In
the reinvestigation anti-band 3 NAbs were further purified by
absorption on heat aggregated human IgG to deplete of anti-
idiotypes. Anti-band 3 NAbs obtained in this manner bound on
blots exclusively to band 3 and to the 55 kDa chymotryptic frag-
ment of band 3, but not the 38 kDa chymotryptic fragment of
band 3 (Lutz et al., 1993a). A detailed analysis further showed
that binding of anti-band 3 NAbs to blotted band 3 protein from
RBC membranes was neither inhibited by pretreating RBC with
neuraminidase nor endo-β-galactosidase. In addition, its binding
to band 3 and to the 55 kDa fragment of band 3 was not inhib-
ited at all by 10μg/ml lactoferrin (Lutz et al., 1993a). This was
in complete contrast to the properties of Beppu’s “anti-band 3
antibodies,” for which these authors showed an 80% inhibition
of binding to oxidatively stressed RBC by 10μg/ml lactoferrin
(Beppu et al., 1992). The consequence was thatmany investigators
in the RBC field considered the specificity of anti-band 3 NAbs as
unresolved, as remaining controversial.
The second round of studying anti-band 3 specificity con-
firmed the initial characterization of anti-band 3 NAb prepara-
tions of Lutz and suggested that Beppu’s group must have used
a different type of starting material that upon purification on
immobilized band 3 protein yielded anti-N-acetyllactosaminyl-
specific IgG and anti-band 3 NAbs. This possibility was later
rendered even more likely, when Ando et al. (1996) showed that
70% of their anti-band 3 antibodies bound to lactoferrin and
30% to a non-glycosylated portion of band 3 protein. The source
of their starting material was ill defined: was serum from per-
sons with blood group AB, (Beppu et al., 1992), blood group
B (Beppu et al., 1990), normal adults (Fujino et al., 2000) and
was further treated for 30min at 56◦C, at least in the first paper
(Beppu et al., 1990). Nevertheless, none of these startingmaterials
could explain the copurification of the two types of antibodies on
band 3 protein. Years later, with additional clinical information
available, Lutz came up with the suggestion that Beppu’s group
must have used serum/plasma from patients with one of themany
autoimmune diseases that are characterized by anti-neutrophil
cytoplasmic antibodies (ANCA) (Lutz, 2012). IgG anti-lactoferrin
is one of the induced autoantibodies in patients with rheuma-
toid arthritis (Kida et al., 2011), systemic lupus erythematosus
(Caccavo et al., 2005), ulcerative colitis (Peen et al., 1993; Teegen
et al., 2009), cholangitis (Muratori et al., 2001), and many other
chronic diseases. In contrast to this, healthy humans have no
IgG anti-lactoferrin at all, as verified by ELISA on 34 (Caccavo
et al., 2005) and 36 (Chikazawa et al., 2000) serum samples and
by immunoblotting (Nässberger et al., 1994). Thus, the purified
IgG antibody preparation from Beppu’s group should not have
been named “anti-band 3 Nab.” Their preparation is evidently a
mixture of NAbs with an induced autoantibody.
On the other hand, the functional properties that Beppu’s
group has described for this mixture of anti-band 3 and anti-
lactoferrin reveal an unexpected implication, namely that not
only anti-band 3 NAbs, but also anti-lactoferrin antibodies bind
to oxidatively stressed and aging RBC and together increase
opsonization with IgG and complement (Beppu et al., 1996; Ando
et al., 1997). The consequence is that patients with induced IgG
anti-lactoferrin antibodies may suffer from anemia as was found
for example in 6 SLE patients having no other ANCA type anti-
body, but anti-lactoferrin (Manolova, 2003). In other studies
anemia accompanying the presence of anti-lactoferrin antibodies
was characterized on the basis of diminished hemoglobin concen-
trations, elevated erythrocyte sedimentation rates (ESR) and/or a
higher red blood cell distribution width (RDW) as for example
in rheumatoid arthritis and SLE (Chikazawa et al., 2000; Caccavo
et al., 2005) and inflammatory bowel diseases (Song et al., 2012).
In these anemias of chronic disease (Weiss and Goodnough, 2005)
erythropoiesis is not increased in proportion to the enhanced
RBC clearance. No one in the medical field has considered the
possibility that extra opsonization of aging RBC by IgG anti-
lactoferrin may result in accelerated removal of normal, aging
RBC and eventually in anemia. The presence of anti-lactoferrin
in IgG eluates from ageing RBC of such patients would provide
the proof.
The anemia developing from the enhanced clearance of aging
RBC by bound anti-band 3 and anti-lactoferrin could be cured by
treatment with human or bovine lactoferrin per os. Lactoferrin
would complex anti-lactoferrin and thereby prevent it from bind-
ing to the 38 kDa fragment of band 3 on aging RBC. Indeed,
treatment with lactoferrin appears to stop anemia of chronic
disease: for example RBC from New Zealand Black mice, consti-
tutively suffering from an autoimmune type RBC clearance, had
fewer numbers of Coombs-positive RBC upon treatment with
bovine lactoferrin (Zimecki et al., 1995). In humans 200mg/day
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of orally applied lactoferrin in combination with erythropoietin
normalized the hemoglobin concentration in 75 cancer patients
with anemia of chronic disease (Macciò et al., 2010). In fact,
lactoferrin was as effective as injection of 125mg ferric gluconate
per week along with erythropoietin, but reduced serum ferritin
significantly. Lactoferrin was also effective in treating pregnant
womenwith iron deficiency anemia: Oral administration of lacto-
ferrin (100mg/twice a day for 30 days), that was iron-saturated
to 30%, increased the total serum iron and hemoglobin con-
centrations to a greater extent than administration of ferrous
sulphate (156 mg/day) in 60 anemic women (Paesano et al., 2009,
2010). These authors also found that the lactoferrin treatment
lowered the serum concentration of IL6 from 32 to 12 pg/ml and
therefore think that this mitigated inhibition of ferroportin 1 on
macrophages and thereby enhanced iron export to blood for effi-
cient erythropoiesis (Paesano et al., 2010). These thoughts call for
clinical trials in which patients with anemia of chronic disease will
be studied for IgG anti-lactoferrin antibodies in their serum and
if positive, will eventually be treated with oral lactoferrin.
OTHER CLEARANCE MECHANISMS
All the above mentioned findings differ completely from the old
idea that desialylation is the trigger for removal of senescent RBC
(Henrich and Aminoff, 1983; Bratosin et al., 1995). Fudenberg
and coworkers addressed this question from a different view-
point and asked whether heat-eluted IgG from senescent RBC
has the same specificity as anti-Thomson-Friedenreich antibodies
(anti-T), that are generated against neuraminidase-treated RBC
glycoproteins. A pretreatment of RBC with anti-T antibodies did
not alter the binding of heat-eluted IgG (Khansari et al., 1983).
Thus, the two binding sites differ from each other and IgG from
senescent RBC do not bind at all to desialylated sites.
“Eryptosis or suicidal erythrocyte death” as portrayed by Lang
et al. (2008) should not be considered a senescence-like mech-
anism in healthy humans. Eryptosis is induced by several types
of stresses, in particular by entry of Ca2+ions followed by the
loss of potassium ions, cell shrinkage, exposure of exoplasmic
phosphatidylserine, and recognition by phagocytes. Eryptosis is
not a senescence variant, because RBC in vivo aged for 110–
126 days do not expose PS as illustrated in chapter 2 (Franco
et al., 2013). In fact Lang and coworkers have recently studied
eryptosis on young and old human RBC and confirmed that
PS exposure was similarly negligible in young and old RBC, but
increased upon induction of eryptosis more so in old than young
RBC (Ghashghaeinia et al., 2012). Eryptosis may contribute to
accelerated RBC clearance in a number of systemic diseases like
hemolytic uremic syndrome and in sepsis (Lang et al., 2008).
There were reports on yet another mechanism of how senes-
cent RBC may be tagged. Galili and coworkers described anti-
αGal antibodies as representing natural antibodies existing in
the plasma of all humans at high concentrations of up to 1%
of total IgG (Galili et al., 1986). Most of bound IgG could
be stripped off from old RBC by galactose and RBC stripped
from bound IgG were phagocytosed upon addition of anti-αGal.
Clark and collaborators reinvestigated the role of anti-αGal and
found that in eluates from senescent RBC 9–39% of total IgG
had anti-αGal and 5–18% anti-band 3 specificity (Clark and
Sorette, 1991). Considering the fact that human plasma contains
100–1000 timesmore anti-αGal than anti-band 3NAbs, the reten-
tion of anti-αGal antibodies was due to incomplete removal by
washing. A year later Galili and coworkers no longer reported
that anti-αGal could be involved in removal of aged human
RBC, because human cells lack the α1,3Gal structure, while this
epitope has been found on surface glycoconjugates of other mam-
malian cells and on many bacterial surfaces (Hamadeh et al.,
1992). In fact, anti-αGal is most likely an induced antibody rather
than a NAb.
After Lutz had isolated and characterized anti-spectrin NAbs
from human IgG, Wiener et al. found significantly increased
plasma concentrations of anti-spectrin NAbs in splenectomized
patients with β-thalassemia major and in patients with sickle
cell anemia (Wiener et al., 1986). Surprisingly, eluates from
patients’ RBC also revealed anti-spectrin NAbs. The authors con-
cluded that binding of these NAbs to intact RBC may either
be due to abnormally exposed spectrin or because of a cross-
reaction. Irrespective of the reason for bound anti-spectrin NAbs,
the increased number of bound IgG as such most likely had
a stimulating effect on the clearance of these cells. Berti and
collaborators later reported analogous findings for RBC from
rats and hypertransfused rats, incubated with induced rat anti-
spectrin antibodies (Giuliani et al., 2000). In trying to understand
the phenomenon the group of Lutz reported that an exoplas-
mic cross-linking of band 3 protein on human RBC not only
enhanced binding of anti-band 3, but also that of purified 125I-
iodinated anti-spectrin NAbs 7–10 fold at 0◦C in the presence of
nearly physiological IgG and HSA concentrations (Hornig and
Lutz, 2000). Binding of anti-spectrin NAbs was not competed
by anti-band 3 NAbs and bound anti-spectrin NAbs even stim-
ulated binding of anti-band 3 NAbs by 30%. While anti-spectrin
NAbs bound at physiologic tonicity to band 3 or an associ-
ated protein by virtue of their inherent polyreactivity (Hornig
and Lutz, 2000), their interaction with other components is
increased at low ionic strength (Heegaard, 1993). The role of
anti-spectrin NAbs is most likely to opsonize ghosts, generated
from hemolysing RBC in circulation, as has been studied in detail
(Salhany et al., 2001).
RBC contain a surface protein that protects RBC from being
phagocytosed, CD47 (integrin-associated protein). When RBC
in circulation bump into macrophages, CD47 actively prevents
engulfment by binding to SIRPα on macrophages and this inter-
action provides a “do not eat me signal” [for a review see reference
Matozaki et al. (2009)]. Recently, Burger et al. suggested that
CD47 may act like a molecular switch from suppression to pro-
motion of phagocytosis, when it may facilitate recognition and
phagocytosis of aged RBC by macrophages (Burger et al., 2012).
The authors think that RBC aging induces a conformational
change in CD47 whereby it binds thrombospondin-1 and then
interacts with SIRPα and induces phagocytosis of aged RBC.
The evidence is weak, because the required concentration of
the thrombospondin-1 peptide exceeded the thrombospondin-1
concentration in plasma by 103–104 (Lutz, 2013) and the phe-
nomena had been studied on RBC that (a) were not actively
leucocyte-depleted and (b) were oxidatively damaged by CuSO4
and ascorbic acid rather than in vivo aged.
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CONCLUDING REMARKS
Covered in this review are the mechanisms of senescence of
RBC in healthy humans. These mechanisms may differ for RBC
of patients with hereditary anemias or polycytemia and those
observed in RBC during storage. In these cases calcium uptake,
PS exposure and abnormal alterations in cell volume, membrane
architecture, as well as redox balance may play a much more
important role. The presentation of senescent RBC from healthy
humans to phagocytes is mediated by complement, but initiated
by naturally occurring anti-band 3 antibodies that bind to aggre-
gated band 3 protein. A very similar, additive effect may have
induced anti-lactoferrin antibodies in autoimmune diseases char-
acterized by ANCA. The induced anti-lactoferrin antibodies bind
to the carbohydrate portion of the band 3 protein and appear to
accelerate clearance of otherwise normal senescent RBC and may
induce anemia.
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